Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00735124 · ClinicalTrials.gov registry record · Phase 2
Post-Operative Pain Scores and Analgesic Requirements After Elective Inguinal Herniorrhaphy
A Phase 2 study, sponsored by University of Oklahoma.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT00735124: Clinical Trial Phase 2 study, sponsored by University of Oklahoma.
NCT00735124 is a Phase 2 study that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 5 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00735124, a Phase 2 study, was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
The study will investigate the effects of single dose pre-operative oral dose of gabapentin (1200) on post -operative pain scores and oral analgesic requirements.
Primary Outcome
Post operative pain is reduced when single pre-operative oral dose of
Interventions
- OTHER placebo
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2008-11-06 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Why NCT00735124 stopped before completion
NCT00735124 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00735124 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00735124 about?
NCT00735124 is a clinical study titled "Post-Operative Pain Scores and Analgesic Requirements After Elective Inguinal Herniorrhaphy". The study will investigate the effects of single dose pre-operative oral dose of gabapentin (1200) on post -operative pain scores and oral analgesic requirements.
What is the current status of trial NCT00735124?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2008-11-06. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00735124?
The interventions under investigation include: placebo (OTHER), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT00735124?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00735124's enrollment target sits among peer trials
5 2000th of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI